ARCHIVES

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

This article is from The Cancer Letter archive.

Vol. 13 No. 46 | November 27, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: Shingleton Chairs Cancer Control Committee; Joftes, Price Head Review, Organ Site Branches

September 3, 1976

NCI-Approved Clinical Trials

May 30, 2003

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Patient Advocacy: Breast Cancer Coalition To Hold International Meeting In Brussels

January 17, 1997

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997